Photo Pharmics
Medical Devices, 947 S 500 E, American Fork, Utah, 84003, United States, 1-10 Employees
Phone Number: 80********
Who is PHOTOPHARMICS
PhotoPharmics specialize in treating neurodegenerative disorders through the eyes. We have 30+ years of research and experience in this field, developing specialized light solutions to re...
Read More
-
Headquarters: 947 S 500 E, American Fork, Utah, 84003, United States
-
Date Founded: 2011
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO:
Kent Savage
Email
Phone
Industry: Medical Devices
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from PHOTOPHARMICS
PhotoPharmics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding PhotoPharmics
Answer: PhotoPharmics's headquarters are located at 947 S 500 E, American Fork, Utah, 84003, United States
Answer: PhotoPharmics's phone number is 80********
Answer: PhotoPharmics's official website is https://photopharmics.com
Answer: PhotoPharmics's revenue is Under $1 Million
Answer: PhotoPharmics's SIC: 8731
Answer: PhotoPharmics has 1-10 employees
Answer: PhotoPharmics is in Medical Devices
Answer: PhotoPharmics contact info: Phone number: 80******** Website: https://photopharmics.com
Answer: PhotoPharmics specialize in treating neurodegenerative disorders through the eyes. We have 30+ years of research and experience in this field, developing specialized light solutions to regulate circadian rhythms for SAD, sleep disorders, anxiety, and depression (acquired by Philips-Respironics in 2007). These solutions are now used by millions. Neurodegenerative diseases show retinal deterioration, which may contribute to disease symptoms. These diseases, such as Parkinsons disease, are also accompanied by circadian system dysregulation. Animal research and human pilot trials show that specialized wavelengths of light delivered in the right intensities and at the right time of day could reduce Parkinsons symptoms. As a result of our work in this area, PhotoPharmics developed the use of specific wavelengths of light in Parkinsons and conducted a pivotal human clinical trial to demonstrate its safety and efficacy. The results of the clinical trial will be published in the Autumn of 2018
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month